Cargando…

A rare reason for hospital admission with muscle weakness in the Covid-19 rra: CPT-2 deficiency

INTRODUCTION: Carnitine Palmitoyl Transferase-2 (CPT-2) is a mitochondrial enzyme involved in the pathway of long chain fatty acids. CPT-2 deficiency is a rare autosomal recessive disease. Except for neonatal and severe infantile hepatocardiomuscular forms, the myopathic form diagnosed at later ages...

Descripción completa

Detalles Bibliográficos
Autores principales: Akçay, Seçkin, Talha Şişman, Ibrahim, Yavuz, Dilek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653157/
http://dx.doi.org/10.1210/jcemcr/luac014.038
_version_ 1785136359976992768
author Akçay, Seçkin
Talha Şişman, Ibrahim
Yavuz, Dilek
author_facet Akçay, Seçkin
Talha Şişman, Ibrahim
Yavuz, Dilek
author_sort Akçay, Seçkin
collection PubMed
description INTRODUCTION: Carnitine Palmitoyl Transferase-2 (CPT-2) is a mitochondrial enzyme involved in the pathway of long chain fatty acids. CPT-2 deficiency is a rare autosomal recessive disease. Except for neonatal and severe infantile hepatocardiomuscular forms, the myopathic form diagnosed at later ages often presents with attacks of muscle weakness and recurrent rhabdomyolysis attacks. CLINICAL CASE: A 27-year-old male patient who applied to the emergency department with complaints of pain all over the body, muscle weakness, nausea, vomiting, headache and decreased urine output in the last 2 days. He was consulted because of LDH: 456 U/L (0–248 U/L), CK: 5567 U/L (0–190 U/L), AST: 382 U/L (10–37), ALT: 89.8 U/L (10–40 U/L), creatinine: 1.23 mg/dL (0–1,2 mg/dL). He was interned with the prediagnosis of acute kidney injury secondary to rhabdomyolysis. It was learned that he had been fasting for 2 days and working at an intense physical pace. There were intensive care hospitalizations due to rhabdomyolysis at the age of 16 and 24 years and Reye's syndrome at the age of 15. It was not diagnosed at that time. His mother's cousin when he was 15 had sudden cardiac death. On physical examination, he was conscious and his general condition was poor. Blood pressure: 141/100mmHg, pulse: 76/min, and fever: 37.4. There were 4/5 muscle weakness in bilateral lower extremity proximal muscles 3/5, distal muscles 4/5, upper extremity proximal and distal muscles 4/5. Pre-diagnoses of very long chain fatty acid dehydration deficiency, CPT-2 deficiency, glutaric acidemia type-2 were considered, IV hydration and riboflavin 3×100mg, coenzyme-Q 2×100mg, carnitine 2×1gr mitochondrial cocktail were started. Tandem Mass and urine amino acid levels were requested from the patient who was in the attack period. During his hospitalization, he had increases of acute phase reactants and respiratory symptoms, Covid PCR+ was detected. Liver function tests increased under favipravir treatment. In the follow-up, the values of CK, creatinine and liver function tests ​​decreased with hydration. Homozygous c.338C>T(p.Ser113Leu) mutation was detected in the CPT-2 gene. CONCLUSION: CPT-2 deficiency should be kept in mind as a rare cause of increased muscle weakness after fasting, intense exercise, and all infections, especially Covid and other upper respiratory tract infections. Intense hydration and mitochondrial cocktail therapy should be added to the patient until the diagnosis is clarified.
format Online
Article
Text
id pubmed-10653157
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106531572023-01-27 A rare reason for hospital admission with muscle weakness in the Covid-19 rra: CPT-2 deficiency Akçay, Seçkin Talha Şişman, Ibrahim Yavuz, Dilek JCEM Case Rep Obesity, Metabolism and Nutrition INTRODUCTION: Carnitine Palmitoyl Transferase-2 (CPT-2) is a mitochondrial enzyme involved in the pathway of long chain fatty acids. CPT-2 deficiency is a rare autosomal recessive disease. Except for neonatal and severe infantile hepatocardiomuscular forms, the myopathic form diagnosed at later ages often presents with attacks of muscle weakness and recurrent rhabdomyolysis attacks. CLINICAL CASE: A 27-year-old male patient who applied to the emergency department with complaints of pain all over the body, muscle weakness, nausea, vomiting, headache and decreased urine output in the last 2 days. He was consulted because of LDH: 456 U/L (0–248 U/L), CK: 5567 U/L (0–190 U/L), AST: 382 U/L (10–37), ALT: 89.8 U/L (10–40 U/L), creatinine: 1.23 mg/dL (0–1,2 mg/dL). He was interned with the prediagnosis of acute kidney injury secondary to rhabdomyolysis. It was learned that he had been fasting for 2 days and working at an intense physical pace. There were intensive care hospitalizations due to rhabdomyolysis at the age of 16 and 24 years and Reye's syndrome at the age of 15. It was not diagnosed at that time. His mother's cousin when he was 15 had sudden cardiac death. On physical examination, he was conscious and his general condition was poor. Blood pressure: 141/100mmHg, pulse: 76/min, and fever: 37.4. There were 4/5 muscle weakness in bilateral lower extremity proximal muscles 3/5, distal muscles 4/5, upper extremity proximal and distal muscles 4/5. Pre-diagnoses of very long chain fatty acid dehydration deficiency, CPT-2 deficiency, glutaric acidemia type-2 were considered, IV hydration and riboflavin 3×100mg, coenzyme-Q 2×100mg, carnitine 2×1gr mitochondrial cocktail were started. Tandem Mass and urine amino acid levels were requested from the patient who was in the attack period. During his hospitalization, he had increases of acute phase reactants and respiratory symptoms, Covid PCR+ was detected. Liver function tests increased under favipravir treatment. In the follow-up, the values of CK, creatinine and liver function tests ​​decreased with hydration. Homozygous c.338C>T(p.Ser113Leu) mutation was detected in the CPT-2 gene. CONCLUSION: CPT-2 deficiency should be kept in mind as a rare cause of increased muscle weakness after fasting, intense exercise, and all infections, especially Covid and other upper respiratory tract infections. Intense hydration and mitochondrial cocktail therapy should be added to the patient until the diagnosis is clarified. Oxford University Press 2023-01-27 /pmc/articles/PMC10653157/ http://dx.doi.org/10.1210/jcemcr/luac014.038 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Obesity, Metabolism and Nutrition
Akçay, Seçkin
Talha Şişman, Ibrahim
Yavuz, Dilek
A rare reason for hospital admission with muscle weakness in the Covid-19 rra: CPT-2 deficiency
title A rare reason for hospital admission with muscle weakness in the Covid-19 rra: CPT-2 deficiency
title_full A rare reason for hospital admission with muscle weakness in the Covid-19 rra: CPT-2 deficiency
title_fullStr A rare reason for hospital admission with muscle weakness in the Covid-19 rra: CPT-2 deficiency
title_full_unstemmed A rare reason for hospital admission with muscle weakness in the Covid-19 rra: CPT-2 deficiency
title_short A rare reason for hospital admission with muscle weakness in the Covid-19 rra: CPT-2 deficiency
title_sort rare reason for hospital admission with muscle weakness in the covid-19 rra: cpt-2 deficiency
topic Obesity, Metabolism and Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653157/
http://dx.doi.org/10.1210/jcemcr/luac014.038
work_keys_str_mv AT akcayseckin ararereasonforhospitaladmissionwithmuscleweaknessinthecovid19rracpt2deficiency
AT talhasismanibrahim ararereasonforhospitaladmissionwithmuscleweaknessinthecovid19rracpt2deficiency
AT yavuzdilek ararereasonforhospitaladmissionwithmuscleweaknessinthecovid19rracpt2deficiency
AT akcayseckin rarereasonforhospitaladmissionwithmuscleweaknessinthecovid19rracpt2deficiency
AT talhasismanibrahim rarereasonforhospitaladmissionwithmuscleweaknessinthecovid19rracpt2deficiency
AT yavuzdilek rarereasonforhospitaladmissionwithmuscleweaknessinthecovid19rracpt2deficiency